Helen Louise Collins - Net Worth and Insider Trading
Helen Louise Collins Net Worth
The estimated net worth of Helen Louise Collins is at least $0 dollars as of 2024-11-13. Helen Louise Collins is the CHIEF MEDICAL OFFICER of Enliven Therapeutics Inc and owns about 0 shares of Enliven Therapeutics Inc (ELVN) stock worth over $0. Details can be seen in Helen Louise Collins's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Helen Louise Collins has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Helen Louise Collins
Helen Louise Collins Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Helen Louise Collins owns 3 companies in total, including Five Prime Therapeutics Inc (FPRX) , Kura Oncology Inc (KURA) , and Enliven Therapeutics Inc (ELVN) .
Click here to see the complete history of Helen Louise Collins’s form 4 insider trades.
Insider Ownership Summary of Helen Louise Collins
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2020-08-20 | EVP and Chief Medical Officer |
| KURA | Kura Oncology Inc | 2021-07-28 | director |
| ELVN | Enliven Therapeutics Inc | 2024-10-18 | director |
Helen Louise Collins Latest Holdings Summary
Helen Louise Collins currently owns a total of 1 stock. Helen Louise Collins owns 0 shares of Enliven Therapeutics Inc (ELVN) as of October 18, 2024, with a value of $0.
Latest Holdings of Helen Louise Collins
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics Inc | 2024-10-18 | 0 | 27.14 | 0 |
Holding Weightings of Helen Louise Collins
Helen Louise Collins Form 4 Trading Tracker
According to the SEC Form 4 filings, Helen Louise Collins has made a total of 2 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Enliven Therapeutics Inc is the sale of 816 shares on October 18, 2024, which brought Helen Louise Collins around $24,480.
Insider Trading History of Helen Louise Collins
- 1
Helen Louise Collins Trading Performance
Helen Louise Collins Ownership Network
Ownership Network List of Helen Louise Collins
Ownership Network Relation of Helen Louise Collins
Helen Louise Collins Owned Company Details
What does Five Prime Therapeutics Inc do?
Who are the key executives at Five Prime Therapeutics Inc?
Helen Louise Collins is the EVP and Chief Medical Officer of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and 10 percent owner Bvf Partners L P/il .
Five Prime Therapeutics Inc (FPRX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Five Prime Therapeutics Inc Insider Transactions
Helen Louise Collins Mailing Address
Above is the net worth, insider trading, and ownership report for Helen Louise Collins. You might contact Helen Louise Collins via mailing address: Two Corporate Drive, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
